Allianz Asset Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Allianz Asset Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-52,600	Closed	-$2.44K	–	2295
2023 Q2	$2.44K	Buy	+52,600	New	+$1.82M	﹤0.01%	2010

Allianz Asset Management's DICE Position: Q3 2023 in Review

Allianz Asset Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 52,600 shares — an estimated $2.44K sold.

Allianz Asset Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $2.44K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Allianz Asset Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Allianz Asset Management sold 52,600 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.44K.
Allianz Asset Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Allianz Asset Management's DICE Therapeutics, Inc. Common Stock position peaked at $2.44K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Allianz Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.